@biochemcompsci.bsky.social
Reposted
Congratulations to the Valora Therapeutics team on an exciting launch; it is a privilege to work with cofounders @jcstark.bsky.social at MIT/Koch Inst and biotech veteran/CEO Miguel Garcia-Guzman, bringing the #AbLec technology to patients. #glycotime
endpts.com/carolyn-bert...
endpts.com/carolyn-bert...
Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy
Valora Therapeutics has $30 million to jumpstart research on immunotherapies based on sugars — the kind that dots cell surfaces and help devastating cancers evade immune system attack.
endpts.com
November 20, 2024 at 5:57 PM
Congratulations to the Valora Therapeutics team on an exciting launch; it is a privilege to work with cofounders @jcstark.bsky.social at MIT/Koch Inst and biotech veteran/CEO Miguel Garcia-Guzman, bringing the #AbLec technology to patients. #glycotime
endpts.com/carolyn-bert...
endpts.com/carolyn-bert...